446 related articles for article (PubMed ID: 33814284)
1. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
2. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.
Bazemore K; Rohly M; Permpalung N; Yu K; Timofte I; Brown AW; Orens J; Iacono A; Nathan SD; Avery RK; Valantine H; Agbor-Enoh S; Shah PD
J Heart Lung Transplant; 2021 Nov; 40(11):1454-1462. PubMed ID: 34344623
[TBL] [Abstract][Full Text] [Related]
3. Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.
Agbor-Enoh S; Wang Y; Tunc I; Jang MK; Davis A; De Vlaminck I; Luikart H; Shah PD; Timofte I; Brown AW; Marishta A; Bhatti K; Gorham S; Fideli U; Wylie J; Grimm D; Goodwin N; Yang Y; Patel K; Zhu J; Iacono A; Orens JB; Nathan SD; Marboe C; Berry GJ; Quake SR; Khush K; Valantine HA
EBioMedicine; 2019 Feb; 40():541-553. PubMed ID: 30692045
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.
Jang MK; Tunc I; Berry GJ; Marboe C; Kong H; Keller MB; Shah PD; Timofte I; Brown AW; Ponor IL; Mutebi C; Philogene MC; Yu K; Iacono A; Orens JB; Nathan SD; Agbor-Enoh S
J Heart Lung Transplant; 2021 Aug; 40(8):822-830. PubMed ID: 34130911
[TBL] [Abstract][Full Text] [Related]
5. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.
Agbor-Enoh S; Tunc I; De Vlaminck I; Fideli U; Davis A; Cuttin K; Bhatti K; Marishta A; Solomon MA; Jackson A; Graninger G; Harper B; Luikart H; Wylie J; Wang X; Berry G; Marboe C; Khush K; Zhu J; Valantine H
J Heart Lung Transplant; 2017 Sep; 36(9):1004-1012. PubMed ID: 28624139
[TBL] [Abstract][Full Text] [Related]
6. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free DNA to Detect Heart Allograft Acute Rejection.
Agbor-Enoh S; Shah P; Tunc I; Hsu S; Russell S; Feller E; Shah K; Rodrigo ME; Najjar SS; Kong H; Pirooznia M; Fideli U; Bikineyeva A; Marishta A; Bhatti K; Yang Y; Mutebi C; Yu K; Kyoo Jang M; Marboe C; Berry GJ; Valantine HA;
Circulation; 2021 Mar; 143(12):1184-1197. PubMed ID: 33435695
[TBL] [Abstract][Full Text] [Related]
8. Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction.
Bazemore K; Permpalung N; Mathew J; Lemma M; Haile B; Avery R; Kong H; Jang MK; Andargie T; Gopinath S; Nathan SD; Aryal S; Orens J; Valantine H; Agbor-Enoh S; Shah P
Am J Transplant; 2022 Nov; 22(11):2560-2570. PubMed ID: 35729715
[TBL] [Abstract][Full Text] [Related]
9. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701
[No Abstract] [Full Text] [Related]
10. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
[TBL] [Abstract][Full Text] [Related]
11. Genetic effect of ischemia-reperfusion injury upon primary graft dysfunction and chronic lung allograft dysfunction in lung transplantation: evidence based on transcriptome data.
Zheng XY; Huang H; Wei ZT; Yan HJ; Wang XW; Xu L; Li CH; Tang HT; Wang JJ; Yu ZW; Tian D
Transpl Immunol; 2022 Apr; 71():101556. PubMed ID: 35202801
[TBL] [Abstract][Full Text] [Related]
12. Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction.
Greenland JR; Guo R; Lee S; Tran L; Kapse B; Kukreja J; Hays SR; Golden JA; Calabrese DR; Singer JP; Wolters PJ
J Heart Lung Transplant; 2023 Dec; 42(12):1700-1709. PubMed ID: 37648073
[TBL] [Abstract][Full Text] [Related]
13. Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
Agbor-Enoh S; Jackson AM; Tunc I; Berry GJ; Cochrane A; Grimm D; Davis A; Shah P; Brown AW; Wang Y; Timofte I; Shah P; Gorham S; Wylie J; Goodwin N; Jang MK; Marishta A; Bhatti K; Fideli U; Yang Y; Luikart H; Cao Z; Pirooznia M; Zhu J; Marboe C; Iacono A; Nathan SD; Orens J; Valantine HA; Khush K
J Heart Lung Transplant; 2018 Jul; 37(7):925-932. PubMed ID: 29500138
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.
Shen J; Zhou Y; Chen Y; Li X; Lei W; Ge J; Peng W; Wu J; Liu G; Yang G; Shi H; Chen J; Jiang T; Wang R
Transpl Int; 2019 Feb; 32(2):184-192. PubMed ID: 30198148
[TBL] [Abstract][Full Text] [Related]
15. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction.
Dugger DT; Calabrese DR; Gao Y; Deiter F; Tsao T; Maheshwari J; Hays SR; Leard L; Kleinhenz ME; Shah R; Golden J; Kukreja J; Gordon ED; Singer JP; Greenland JR
Front Immunol; 2021; 12():704172. PubMed ID: 34691018
[TBL] [Abstract][Full Text] [Related]
16. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
[TBL] [Abstract][Full Text] [Related]
17. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
18. Plasma Donor-Derived Cell-Free DNA Levels Are Associated With the Inflammatory Burden and Macrophage Extracellular Trap Activity in Renal Allografts.
Guo L; Shen J; Lei W; Yan P; Wang M; Zhou Q; Wang H; Wu J; Chen J; Wang R
Front Immunol; 2022; 13():796326. PubMed ID: 35386710
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
20. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.
Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D
Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
